Literature DB >> 3175455

Deposition pattern of nasal sprays in man.

S P Newman1, F Morén, S W Clarke.   

Abstract

The intranasal distribution from an aqueous pump spray has been assessed in 13 normal subjects, using insoluble Teflon particles labelled with 99Tcm which were intended to simulate a suspension of drug particles. Three different combinations of metered volume and spray cone angle were compared. The main deposition of particles was in the anterior, non-ciliated, part of the nose, but some particles also penetrated more posteriorly into the main nasal passages and were cleared subsequently to the nasopharynx. No particles were detected in the lungs. With a single puff of 100 microliters volume, 46.5 +/- 4.4 (mean +/- SEM)% of the spray was retained in the anterior part of the nose after 30 minutes, but this was increased to 57.1 +/- 4.5% (P less than 0.05) with two puffs of 50 microliters. The latter were deposited over a significantly (P less than 0.05) smaller area in the nasal cavity. There was a trend towards lower particle retention and a greater area of deposition when the spray cone angle was decreased from 60 degrees to 35 degrees. These results indicate that the drug particles released from nasal pump sprays are distributed both to ciliated and non-ciliated zones, and that the choice of metered volume and possibly spray cone angle may play a role in determining the amount which penetrates to the main nasal passages.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3175455

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  10 in total

1.  Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.

Authors:  L Thorsson; O Borgâ; S Edsbäcker
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

2.  Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.

Authors:  Julie D Suman; Beth L Laube; Ta-Chun Lin; Guillaume Brouet; Richard Dalby
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

3.  Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump.

Authors:  J D Suman; B L Laube; R Dalby
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

Review 4.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade Impactor.

Authors:  William H Doub; Wallace P Adams; Anna M Wokovich; John C Black; Meiyu Shen; Lucinda F Buhse
Journal:  Pharm Res       Date:  2012-07-03       Impact factor: 4.200

6.  High resolution visualization and analysis of nasal spray drug delivery.

Authors:  Kiao Inthavong; Man Chiu Fung; Xuwen Tong; William Yang; Jiyuan Tu
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

Review 7.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

8.  Current understanding of nasal morphology and physiology as a drug delivery target.

Authors:  Julie D Suman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

Review 9.  Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.

Authors:  Yung Sung Cheng
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

10.  Effect of Variable Inspiratory Flow Rate on the Performance of the Budesonide Rhinocort Turbuhaler™.

Authors:  J L Devalia; D Prime; D H Richards
Journal:  Clin Drug Investig       Date:  2001-03       Impact factor: 2.859

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.